14-day Premium Trial Subscription Try For FreeTry Free
$3.54
+0.0750 (+2.16%)
At Close: May 28, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Inventiva S.A.

Inventiva S.A. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype ... IVA Profile

Golden Star

Ticker Date Change Price
OHI May 20 0.84% $30.86
TTWO May 16 7.33% $146.08
RL May 15 8.55% $166.98
HLN May 13 1.70% $8.25
BJRI May 10 3.35% $33.75
DYN May 10 15.42% $26.00
NVO May 08 5.83% $126.69
WMT May 06 8.64% $59.87
JPM May 06 3.91% $192.00
ASH May 03 4.44% $95.85
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT